Microbiome/transforming growth factor-β axis as a diagnostic and therapeutic target for MASLD in Egyptian patients.

Gut Pathog · 2026 · PMC13088655 · PMID 41965779

Europe PMC DOI

hedged sentences

0.0010

closest p · 0.0× alpha

0.0720

boldest claim

The sentences

highly significantp < 0.001actually significant

Our study showed that the gene expression level of TGF-β was significantly elevated in MASLD patients (median: 163.14; IQR: 163.14–218.27) compared to controls (median: 1.97; IQR: 1.97–29.04), with a highly significant difference ( p < 0.001).

also in 132,142 other papers

did not reach statistical significancep = 0.072so close (0.05 < p ≤ 0.1)

Although SOD levels trended lower in MASLD patients, the difference did not reach statistical significance ( p = 0.072).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.